丘瑞香,贺敬波,蓝军.心脉通胶囊保护血管内皮细胞损伤的临床研究[J].中国中西医结合杂志,1998,(2):74-76 |
心脉通胶囊保护血管内皮细胞损伤的临床研究 |
Clinical Study on Protective Effect of Xinmaitong Capsule on Damage of Vascular Endothelial Cells |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 心脉通胶囊 血管内皮细胞 内皮素 降钙素基因相关肽 |
英文关键词:Xinmaitong Capsule vascular endothelial cells endothelin calcitonin gene-related peptide. |
基金项目:广东省中医药管理局资助!94081 |
|
摘要点击次数: 1279 |
全文下载次数: 1142 |
中文摘要: |
探讨心脉通胶囊对冠心病心肌缺血的治疗作用。方法: 38例冠心病心肌缺血患者在常规西药治疗基础上随机分为心脉通组(20例,加用心脉通胶囊治疗),对照组(18例),观察治疗前后血浆内皮素(ET)、降钙素基因相关肽(CGRP)含量,心电图ST段和临床症状等的变化,并与14名健康人作对比。结果:治疗前两组冠心病心肌缺血患者ET明显高于健康人(P< 0. 01), CGRP变化不明显(P> 0.05)。治疗后两组患者 ET及症状计分均明显降低( P< 0. 01), ST段均明显升高( P< 0. 01),但心脉通组 ET、症状计分降低及 ST段上升幅度明显大于对照组(P<0.05~P<0.01);对照组CGRP变化不明显(P>0.05),心脉通组CGRP明显提高(P<0.01)。结论:冠心病患者存在严重血管内皮损伤,心脉通胶囊能抑制血浆ET的过量释放,同时有促进血浆CGRP的生成和分泌作用并有良好的抗心肌缺血作用,其作用与改善血管内皮细胞功能,调整 ET和CGRP代谢有关。 |
英文摘要: |
To assess the effect of Xinmaitong (XMT) capsule in treating coronary heart disease (CHD). Methods: Thirty-eight patients of coronary heart disease with myocardial ischemia were divided randomly into XMT group (20 cases) and control group (18 cases). Conventional western medical therapy was given to both groups and the XMT group received additional XMT treatment. The changes of endothelin (ET) and calcitonin gene-related peptide (CGRP) levels, ST segment of ECG and clinical symptoms after treatment in all the patients were observed. Data of 14 healthy persons were taken as normal control. Results: The ET level of all patients was significantly higher than that of the normal control (P<0.001), and level of CGRP in patients was not different from normal control significantly (P>0.05). After treatment, results showed that: (1) The ET levels and the scores of clinical symptoms of both groups decreased significantly (P<0.01), and ST segment elevated markedly (P<0.01) as compared with before treatment, and the changes revealed more evident in XMT group in comparison with those of the control group (P<0. 05~P<0.01). (2) The level of CGRP was significantly increased in XMT group (P<0.01) while unchanged in the control group (P>0.05). Conclusions: There is severe damage of vascular endothelial cells in CHD patients. XMT could not only reduce significantly the plasma ET content, but also enhance markedly the production and release of CGRP, so it has a good anti-ischethec effect, which may be closely related with its action on improving the function of vascular endothelial cells and regulating metabolism of ET and CGRP. |
关闭 |